BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Telerik Inc.//Sitefinity CMS 15.4//EN
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
DTSTART;VALUE=DATE:20250101
TZNAME:UTC
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:EFSPI Data Sharing Working Group\n\nWednesday 21st June 2017\n2
 .30-4.30pm (UK time)\n\n\nData Sharing and Data Privacy - what every stati
 stician needs to know\nData sharing\, data transparency and data privacy a
 re areas that continue to evolve. For example\, EMA Policy 70 is now effec
 tive with proactive publication of submitted clinical overviews and study 
 reports. It is becoming more common for clinical trial data to be used to 
 support scientific questions beyond the objectives of the original study.\
 nThe intent of this webinar is to provide an outline to pharmaceutical sta
 tisticians of key issues and concepts everyone dealing with and sharing pa
 tient level data should be aware of.\nPresentation #1 Sharing clinical tri
 al data externally &ndash\; key data privacy concepts every statistician s
 hould know (Janice Branson and Nicola Orlandi (Novartis))\nClick here to v
 iew the slides\nPresentation #2 Data Sources to help inform drug developme
 nt &ndash\; what you give is also what you get (Sally Hollis (Phastar) and
  Rebecca Sudlow (Roche))\nClick here to view the slides\nTo access the rec
 ording\, please visit the Video-on-Demand Library.
DTEND:20170621T163000Z
DTSTAMP:20260908T030023Z
DTSTART:20170621T143000Z
LOCATION:
SEQUENCE:0
SUMMARY:PSI Webinar: Data Sharing and Data Privacy - what every statisticia
 n needs to know
UID:RFCALITEM639244332238256211
X-ALT-DESC;FMTTYPE=text/html:<p style="text-align: center\;"><strong>EFSPI 
 Data Sharing Working Group<br />\n<br />\nWednesday 21st June 2017<br />\n
 2.30-4.30pm (UK time)<br />\n<br />\n</strong></p>\n<p style="text-align: 
 center\;"><strong>Data Sharing and Data Privacy - what every statistician 
 needs to know</strong></p>\n<p>Data sharing\, data transparency and data p
 rivacy are areas that continue to evolve. For example\, EMA Policy 70 is n
 ow effective with proactive publication of submitted clinical overviews an
 d study reports. It is becoming more common for clinical trial data to be 
 used to support scientific questions beyond the objectives of the original
  study.</p>\n<p>The intent of this webinar is to provide an outline to pha
 rmaceutical statisticians of key issues and concepts everyone dealing with
  and sharing patient level data should be aware of.</p>\n<p><strong>Presen
 tation #1</strong> Sharing clinical trial data externally &ndash\; key dat
 a privacy concepts every statistician should know (Janice Branson and Nico
 la Orlandi (Novartis))<br />\n<a href="https://www.psiweb.org/docs/default
 -source/default-document-library/anonymization---webinar_jb.pdf?sfvrsn=74e
 8dddb_0&sf_site_temp=true&sf_site=00000000-0000-0000-0000-000000000000" ti
 tle="Anonymization - Webinar_JB">Click here to view the slides</a></p>\n<p
 ><strong>Presentation #2</strong> Data Sources to help inform drug develop
 ment &ndash\; what you give is also what you get (Sally Hollis (Phastar) a
 nd Rebecca Sudlow (Roche))<br />\n<a href="https://www.psiweb.org/docs/def
 ault-source/default-document-library/psi_webinar_21june2017_shrs.pdf?sfvrs
 n=7ee8dddb_0&sf_site_temp=true&sf_site=00000000-0000-0000-0000-00000000000
 0" title="PSI_Webinar_21June2017_SHRS">Click here to view the slides</a></
 p>\n<p><strong>To access the recording\, please visit the <a href="https:/
 /www.psiweb.org/vod">Video-on-Demand Library</a>.</strong></p>
END:VEVENT
END:VCALENDAR